Investment
Features
FeesSafety
Academy
More
Pluang+

Coinbase to launch PONS-USD spot trading on Oct 7, subject to liquidity and regional availability.

Market News
07 Oct 2026
Tokenpost
View Source
Bullish
Coinbase to launch PONS-USD spot trading on Oct 7, subject to liquidity and regional availability.

Coinbase plans to introduce spot trading for the Pons (PONS) token on October 7, allowing eligible users to trade PONS directly against the U.S. dollar. This move expands access to PONS through a major U.S.-based exchange, but the launch depends on meeting liquidity requirements and regional trading support. No specific opening time has been announced yet. This development could increase PONS token liquidity and accessibility for U.S. investors.

Coinbase's plan to open Pons (PONS) spot trading on October 7 comes as a backdrop to a broadly declining cryptocurrency market on Pluang. For readers following digital assets, here is Pluang's market snapshot as of Oct 07, 2026 22:32 WIB: out of 50 major cryptocurrencies, only 5 rose while 44 fell. Notable movers include SUSHI at Rp4.159 with a 9.37% decline and a typical hold time of 101 days, AXS at Rp20.869 down 9.24% with 89% buy order activity, and XTZ at Rp5.475 down 8.54% with 95% sell order activity.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App